PCP, or phencyclidine, is an illicit dissociative drug that can disrupt perception, pain sensation, movement, judgment and the ability to distinguish internal experiences from external reality. It is often placed under the broad hallucinogen label, but its clinical profile is better described as dissociative because intoxication can produce detachment from the body and surroundings, profound analgesia, amnesia, disorganized behavior and a striking mixture of stimulation and sedation.

PCP was developed as a general anesthetic in the 1950s and marketed as Sernyl, but human use was abandoned because patients could emerge from anesthesia with severe dysphoria, hallucinations and other disturbing psychiatric reactions. That medical history is important because PCP is not simply a recreational psychedelic. Its pharmacology can produce a toxic syndrome that involves the brain, cardiovascular system, muscles, temperature regulation and behavior at the same time.

PCP at a Glance

Full name Phencyclidine
Drug class Dissociative anesthetic / dissociative hallucinogen
Primary pharmacology Noncompetitive NMDA receptor antagonism, with additional effects on dopamine, norepinephrine and other receptor systems
Common acute pattern Dissociation, numbness, impaired coordination, abnormal eye movements, confusion, agitation or psychosis
Serious complications Seizures, hyperthermia, rhabdomyolysis, hypertensive crisis, coma, respiratory compromise, intracranial hemorrhage and trauma
Can repeated use become addictive? Yes. PCP abuse and dependence are described in clinical literature
Specific antidote No. Severe intoxication is treated with supportive and symptom-directed emergency care

How PCP Works and Why Its Effects Are So Unusual

Why PCP is called a dissociative

Dissociation is more than ordinary intoxication or visual hallucination. It is a disruption in the normal integration of perception, memory, body awareness and the sense of reality. A person may feel separated from the body, believe the environment is unreal, lose a normal sense of physical limits or appear awake while responding to events in a profoundly altered way.

PCP’s dissociative effects are closely tied to blockade of NMDA-type glutamate receptors. Glutamate is the brain’s major excitatory neurotransmitter and NMDA receptors are involved in learning, memory, sensory integration and cortical processing. When PCP interferes with this system, the result can be analgesia, amnesia, cognitive disruption and psychosis rather than a simple increase or decrease in alertness.

Why PCP can look like both a stimulant and a depressant

One of the defining clinical problems with PCP is that its presentation can vary from lethargy or coma to severe agitation, paranoia and violent or chaotic behavior. NCBI’s clinical review describes a spectrum from profound CNS depression to extreme excitation. This mixed pattern reflects the fact that PCP acts on more than one neurochemical system.

NMDA receptor blockade contributes to dissociation, anesthesia and psychosis. PCP also inhibits the reuptake of dopamine and norepinephrine, which can contribute to hypertension, tachycardia and agitation. Additional receptor effects can produce sedation. This combination explains why trying to categorize PCP as merely an “upper” or “downer” misses its real toxicology.

What PCP Intoxication Looks Like in the Body and Behavior

Core clinical pattern

Classic findings include altered mental status, abnormal eye movements, hypertension, impaired coordination and changes in muscle tone. Nystagmus, particularly horizontal or vertical involuntary eye movement, is one of the better-known examination findings. The person may also have slurred or disorganized speech, ataxia, numbness or unusual motor behavior.

The psychiatric presentation can be just as prominent. Hallucinations, delusions, severe suspiciousness and disorganized thinking may resemble schizophrenia or stimulant psychosis. Some people become frightened and withdrawn. Others become severely agitated. The same patient can fluctuate between states over the course of intoxication.

The myth of “superhuman strength”

PCP is often surrounded by sensational stories about impossible physical strength. The more clinically accurate explanation is a combination of severe agitation, impaired judgment, altered body awareness and reduced pain perception. A person may continue struggling or moving despite injuries that would normally limit activity, which can make behavior appear unusually forceful.

This distinction matters because the myth can encourage dangerous responses. PCP intoxication does not make the body indestructible. It can make the person less aware of injury while simultaneously increasing the likelihood of falls, collisions, restraint-related injury and muscle breakdown. De-escalation and trained medical management are safer than assuming confrontation is required.

Reduced pain perception and hidden injury

Analgesia is not protective. It can hide fractures, cuts, burns, head injury and other trauma. The person may deny pain, continue walking on an injured limb or fail to report a significant wound. Clinical reviews therefore emphasize a careful trauma examination even when the patient does not complain of pain.

This is also one reason accidental injury is such an important part of PCP morbidity. In a large clinical series of acute intoxication, injuries occurred in a meaningful proportion of patients. Toxicity is not limited to what the drug does directly to organs. It also changes behavior and perception in ways that expose the person to external danger.

Severe Medical Complications of PCP Toxicity

Blood pressure and cardiovascular complications

Hypertension is common in PCP toxicity. StatPearls reports hypertension in a majority of cases described in clinical series, while tachycardia is also common. The mechanism includes sympathomimetic effects from altered catecholamine signaling as well as agitation and muscular activity.

Most elevated blood pressure does not automatically mean a stroke or heart attack has occurred, but severe hypertension changes the risk. Reported complications include myocardial infarction and intracranial hemorrhage. Chest pain, focal neurologic deficits, collapse or severe persistent hypertension therefore require medical evaluation rather than reassurance that the symptoms are “just PCP.”

Muscle activity and rhabdomyolysis

PCP can cause muscle rigidity, seizures and prolonged psychomotor agitation. These states sharply increase skeletal-muscle energy demand. When muscle cells cannot maintain normal energy-dependent ion gradients, cell membranes and intracellular structures begin to fail, releasing creatine kinase, potassium, phosphate and myoglobin into the bloodstream. That process is rhabdomyolysis.

Rhabdomyolysis matters because it can lead to dangerous electrolyte abnormalities and acute kidney injury. Myoglobin released from damaged muscle can contribute to renal injury, particularly when dehydration and other physiologic stressors are also present. Clinicians may therefore check creatine kinase, kidney function, electrolytes and urinalysis in significant PCP toxicity.

Hyperthermia

Dangerously high body temperature can develop when severe agitation, muscle rigidity or seizures generate heat faster than the body can dissipate it. Hyperthermia then worsens muscle injury and can contribute to rhabdomyolysis, kidney injury and broader organ dysfunction.

At the extreme end of toxicity, hyperthermia can become part of a cascading syndrome involving coma, rhabdomyolysis, shock and organ failure. This is why a very hot, rigid, severely agitated or confused patient needs emergency treatment rather than passive observation.

Seizures

Yes. Seizures are a recognized complication of severe PCP toxicity. They can arise from the drug’s direct neurologic effects and can amplify other complications by increasing oxygen demand, muscle activity and body temperature.

A seizure also creates secondary risks. The person can aspirate, sustain head trauma or develop rhabdomyolysis from sustained muscle contraction. In emergency care, seizures are treated as part of the full toxic syndrome, with attention to airway protection, temperature, glucose, electrolytes and other possible substances.

Coma and breathing problems

Yes. Severe PCP intoxication can progress to stupor or coma. Respiratory depression requiring intubation is not the most common presentation, but irregular breathing, apnea and airway problems are described in clinical reviews. Reduced consciousness also increases aspiration risk.

Slow or abnormal breathing should raise immediate concern for co-ingested opioids as well, because illicit drug exposure is frequently polysubstance. Naloxone does not reverse PCP, but it can still be lifesaving when an opioid component is present.

Psychosis, Addiction and What Happens After the Acute High

PCP psychosis is more than a “bad trip”

PCP can produce a true substance-induced psychotic state with hallucinations, fixed delusions, severe paranoia, disorganization and loss of reality testing. Historical clinical reports describe psychotic reactions lasting days or weeks in some patients, especially after heavy or repeated use.

The distinction from an ordinary distressing intoxication matters because persistent psychosis may require psychiatric hospitalization, antipsychotic treatment and follow-up after the immediate drug effect has faded. See PCP Psychosis for the full discussion.

Detection does not equal current impairment

Urine testing can remain positive after the obvious intoxication has resolved, particularly in chronic users. A positive urine result therefore demonstrates exposure, not necessarily current impairment. Screening immunoassays can also produce false-positive PCP results with certain medications, which is why confirmatory testing matters when the result is unexpected or high stakes.

See How Long Does PCP Stay in Your System? for the testing evidence and limitations.

Addiction and compulsive use

Yes. Clinical literature describes PCP abuse and dependence, and MedlinePlus notes that repeated use can become psychologically addictive and lead to tolerance. Addiction is better identified by loss of control and continued use despite harm than by whether the person has a dramatic physical withdrawal syndrome.

A person may repeatedly return to PCP despite psychosis, accidents, legal problems, relationship damage or previous hospitalizations. That pattern is clinically meaningful even if the interval between intoxication episodes is long.

Withdrawal and early abstinence

Repeated PCP users can experience depression, anxiety, irritability, restlessness, sleep disturbance and craving after stopping. Older clinical literature also reports autonomic and motor symptoms in chronic exposure, but the evidence base is much thinner than for alcohol, opioids or benzodiazepines.

The practical point is that PCP withdrawal should not be dismissed as nonexistent, but it also should not be presented as a standardized medically dangerous syndrome with a fixed detox protocol. See PCP Withdrawal.

When PCP Intoxication Requires Emergency Care

Emergency evaluation is appropriate for seizure, coma, abnormal breathing, severe agitation, very high body temperature, chest pain, major trauma, severe confusion, dangerous psychosis or new neurologic deficits. The person should also be evaluated urgently if they cannot be kept physically safe.

Severe intoxication is treated supportively. Clinicians stabilize airway, breathing and circulation, manage agitation or seizures, control hyperthermia, evaluate for trauma and monitor for complications such as rhabdomyolysis or kidney injury. There is no single antidote that reverses PCP.

Frequently Asked Questions About PCP

Is PCP a hallucinogen?

PCP can cause hallucinations, but it is more specifically classified as a dissociative drug because it disrupts perception, body awareness, memory and reality processing.

Why can PCP make people seem unusually strong?

Severe agitation, reduced pain perception and impaired judgment can make people continue physical activity despite injury. PCP does not make the body physically superhuman.

Can PCP cause permanent problems?

Repeated use has been associated with persistent cognitive, mood and psychotic symptoms in some patients, although individual outcomes vary.

Does naloxone reverse PCP?

No. Naloxone reverses opioids, not PCP, but it is still appropriate when opioid co-exposure is possible and breathing is depressed.

Is a positive PCP urine test proof someone is still high?

No. PCP can remain detectable after acute impairment has resolved, especially after repeated use.

Sources

Part of the PCP (Phencyclidine) resource silo

Continue exploring PCP (Phencyclidine)

Follow the topic in sequence or browse the full PCP (Phencyclidine) resource hub.

About This Article
Evidence-based sourcesSources verified August 17, 2026

Editorial standard

Rehabs.Today resource articles are written for educational and treatment-navigation purposes. For medical and drug-safety claims, we prioritize current primary or authoritative references such as FDA and DailyMed labeling, CDC, SAMHSA, NIH/NCBI resources, and peer-reviewed research when appropriate. Important limitations, uncertainty, and differences between population-level evidence and individual medical advice are stated where they matter.

How to use this information

This article provides general educational information. It is not a diagnosis, prescription, personalized taper, or substitute for advice from a physician, pharmacist, or other qualified healthcare professional. Do not start, stop, combine, or change a prescribed medication solely because of information on this page.

Emergency information

If someone cannot be awakened, is breathing slowly or abnormally, or may be experiencing an opioid overdose, seek emergency medical help immediately and give naloxone if it is available.

Treatment-directory transparency

Some Rehabs.Today articles link to treatment directories and provider resources. Those links are for navigation and do not replace independent medical assessment. Medical claims in the article should be evaluated from the cited evidence, not from whether a treatment provider is linked.